Erschienen in:
01.02.2014 | Letter
Acute kidney injury: taking aim at colistin
verfasst von:
Shayan Rashid, Lilian Saro-Nunez, Akanksha Kumar, Amit Patel, Amay Parikh
Erschienen in:
Critical Care
|
Ausgabe 1/2014
Einloggen, um Zugang zu erhalten
Excerpt
We appreciate the contribution of Rocco and colleagues [
1], whose retrospective study in a recent issue of
Critical Care evaluated risk factors for acute kidney injury (AKI) in patients receiving colistin methanesulfonate (CMS) or other nephrotoxic antimicrobials. The following key thoughts occurred to us after reviewing the study. …